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Abstract
Background: Viral transformation of a cell starts at the genetic level, followed by changes in the proteome and the
metabolome of the host. There is limited information on the broad metabolic changes in HTLV transformed cells.
Methods and Principal Findings: Here, we report the detection of key changes in metabolites and lipids directly from
human T-lymphotropic virus type 1 and type 3 (HTLV1 and HTLV3) transformed, as well as Tax1 and Tax3 expressing cell
lines by laser ablation electrospray ionization (LAESI) mass spectrometry (MS). Comparing LAESI-MS spectra of non-HTLV1
transformed and HTLV1 transformed cells revealed that glycerophosphocholine (PC) lipid components were dominant in
the non-HTLV1 transformed cells, and PC(O-32:1) and PC(O-34:1) plasmalogens were displaced by PC(30:0) and PC(32:0)
species in the HTLV1 transformed cells. In HTLV1 transformed cells, choline, phosphocholine, spermine and glutathione,
among others, were downregulated, whereas creatine, dopamine, arginine and AMP were present at higher levels. When
comparing metabolite levels between HTLV3 and Tax3 transfected 293T cells, there were a number of common changes
observed, including decreased choline, phosphocholine, spermine, homovanillic acid, and glycerophosphocholine and
increased spermidine and N-acetyl aspartic acid. These results indicate that the lipid metabolism pathway as well as the
creatine and polyamine biosynthesis pathways are commonly deregulated after expression of HTLV3 and Tax3, indicating
that the noted changes are likely due to Tax3 expression. N-acetyl aspartic acid is a novel metabolite that is upregulated in
all cell types and all conditions tested.
Conclusions and Significance: We demonstrate the high throughput in situ metabolite profiling of HTLV transformed and
Tax expressing cells, which facilitates the identification of virus-induced perturbations in the biochemical processes of the
host cells. We found virus type-specific (HTLV1 vs. HTLV3), expression-specific (Tax1 vs. Tax3) and cell-type–specific (T
lymphocytes vs. kidney epithelial cells) changes in the metabolite profiles. The new insight on the affected metabolic
pathways can be used to better understand the molecular mechanisms of HTLV induced transformation, which in turn can
result in new treatment strategies.
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Introduction
Human T-lymphotropic virus type 1 (HTLV1), a member of
the delta-retroviridae subfamily, was the first human pathogenic
retrovirus discovered and found to contribute to cancer develop-
ment [1,2]. Infection with HTLV1 has been shown to result in the
development of adult T-cell leukemia (ATL), a CD4
+ T
lymphoproliferative malignancy. Estimates of worldwide HTLV1
infections are currently 15 to 25 million individuals. However,
infected individuals develop ATL after a long latent period and at
a 3-5% incidence rate. Evidence has also linked HTLV1 infection
with HTLV1-associated myelopathy/tropical spastic paraparesis
PLoS ONE | www.plosone.org 1 September 2010 | Volume 5 | Issue 9 | e12590(HAM/TSP; [3]) and several inflammatory diseases including
polymyositis [4], uveitis [5], and lymphocyte alveolitis [6]. The
development of ATL from HTLV1 infection is thought to be a
multi-hit occurrence with initial transformation due to the viral
protein Tax1. Recent studies have indicated that the use of novel
treatments, including monoclonal antibodies against the interleu-
kin-2 receptor (IL-2R) and the combination therapy of interferon-
alpha (IFN-a) and zidovudine (AZT), to be effective, but only in a
small percentage of ATL patients. Therefore, new therapies are
needed for the treatment of ATL or more specifically, HTLV1
infection.
Viral-induced transformation causes extensive changes at the
gene, protein and metabolite levels. These changes are usually
followed by gene-expression profiling and proteomic analysis [7,8].
Exploring the metabolic consequences of viral transformation adds
to the picture because the viruses rely on the metabolic network of
their cellular hosts for survival and replication [9,10,11]. Genomic,
proteomic and metabolomic technologies have not only provided
the foundation for the enhanced understanding of cell biology, but
they are also emerging as tools for identifying disease biomarkers
and for drug development. When compared to the transcriptome
and the proteome, monitoring of the metabolome is useful because
the metabolic composition of a cell/tissue provides its actual
biochemical condition. Although metabolic technologies have
been applied to find biomarkers for a few cancerous and virally
transformed cell types [9,12,13,14,15], these techniques need to be
expanded for challenging viral transformations, such as human
immunodeficiency virus (HIV) and HTLV1.
The insight gained by such studies depends on the target
sample, the treatment procedures and the detection techniques
used. Conventionally, biofluids such as blood and urine have been
used to follow metabolic changes after infection, but in many cases
they complicate the analysis due to the pooling of changes in
different cell types and the variations between individuals
[16,17,18]. Ultimately, direct analysis of cells/tissues is a more
straightforward way to understand the actual disease-associated
metabolic changes occurring. In such cases, a direct detection
technique offers key advantages.
Metabolites are small molecules of diverse physico-chemical
properties with greatly different abundance levels that make their
analysis challenging. Typically optical (e.g., Fourier transform
infrared spectrometry), nuclear magnetic resonance (NMR)
[19,20,21] and mass spectrometric techniques in combination
with separation techniques, such as gas chromatography, high
performance liquid chromatography (HPLC) and capillary
electrophoresis, have been used for metabolomic studies
[22,23,24,25,26]. Mass spectrometry (MS) is a technology with
high efficiency [14] that, combined with chromatographic
separations, can provide qualitative and quantitative analyses of
complex samples with high selectivity and sensitivity, as well as a
broad dynamic range. Conventional mass spectrometric methods,
e.g., matrix-assisted laser desorption ionization (MALDI) and
electrospray ionization (ESI), however, are time consuming
because they involve extensive sample preparation steps [27].
The application of direct sampling methods, such as flow injection
ESI, can avoid chromatographic separation [28], but not extensive
sample preparation that can affect sample integrity and, in some
cases, may lead to metabolite degradation. Therefore, many of
these techniques restrict the choice of samples and preclude their
in situ analysis. Some of these problems can be mitigated by the
use of atmospheric pressure ion sources.
Recent advances in atmospheric pressure ion sources, such as
direct analysis in real time (DART) [29,30], desorption electro-
spray ionization (DESI) [31], atmospheric pressure infrared
MALDI (AP IR-MALDI) [32,33,34,35] and laser ablation
electrospray ionization (LAESI) [36,37,38] enabled direct analysis
of tissues and cell samples without sample preparation. Analysis of
cells, cell cultures and cell extracts using DART, DESI and
MALDI techniques are known [39,40,41] but these methods have
their own limitations, such as coverage of analytes, sampling of the
surface only, and quantitation restrictions. The LAESI technique,
developed for in situ tissue and cell analysis, samples the entire
volume of the cells for metabolites and lipid components with
tissue imaging and quantitation capabilities [42,43].
Through the analysis and molecular imaging of various tissue
samples, we have demonstrated that with LAESI it is possible to
simultaneously detect different classes of compounds, for example,
acidic and basic compounds, lipids and fatty acids [44,45].
Relative quantitation of metabolites can be performed by directly
comparing the LAESI signal from different samples [36], whereas
absolute quantitation can be carried out using labeled internal
standards [38]. A limitation of the LAESI technique is that it relies
on the water content of the sample for analysis. Thus samples
without intrinsic water can only be analyzed after wetting them.
Similar to ESI, the LAESI technique is prone to matrix effects.
Consequently, low-abundant metabolites can be missed or masked
in the presence of matrix peaks or other highly abundant
components.
In this contribution we aim to identify metabolic changes in
HTLV1 transformed T lymphocytes by the direct application of
the LAESI method that is rapid and eliminates the need for
sample preparation. We focus on changes related to HTLV
induced transformation or Tax expression that alter the metabolic
profiles in different cell lines. Understanding the role of Tax in
destabilizing key regulators, such as proteins in metabolism and
cell cycle control, may help to identify molecular markers that
contribute to ATL development and define new therapeutic
strategies. We demonstrate that in situ metabolite profiling of
HTLV1 transformed T lymphocytes facilitates the identification of
virus-induced perturbations in the biochemical processes of the
host cell. For comparison purposes, we performed similar
experiments on cells transfected with either the HTLV3 molecular
clone or Tax3 and compared these metabolic profiles with the
results for HTLV1 transformed and Tax1 expressing cells.
Materials and Methods
Materials
The non-HTLV transformed T lymphocyte cells (CEM and
H9) and kidney epithelial cells (293T) ), the HTLV1 transformed
cells (C81 and HUT102), the H9 cells stably transfected with Tax1
of HTLV1 (H9-Tax1) and the 293T cells transfected with HTLV3
(293T-HTLV3) and expressing Tax3 (293T-Tax3) were main-
tained in RPMI 1640 medium containing fetal bovine serum, L-
glutamine (2 mM), penicillin (100 units/ml) and streptomycin
(100 mg/ml). All the medium solutions and buffers were procured
from Quality Biological Inc. (Gaithersburg, MD). All solvents used
for MS were HPLC grade from Acros Organics (Geel, Belgium).
The glacial acetic acid was purchased from Fluka (Munich,
Germany).
Laser Ablation Electrospray Ionization
Laser ablation was performed by a mid-IR laser system. An
optical parametric oscillator (OPO) (Opolette 100, Opotek,
Carlsbad, CA) converted the output of a 100-Hz repetition rate
Nd:YAG laser to mid-IR pulses of 5-ns duration at 2940-nm
wavelength. Beam steering and focusing were accomplished by
gold coated mirrors (PF10-03-M01, Thorlabs, Newton, NJ) and a
Viral Transformation of Cells
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Farmingdale, NY), respectively. At ,5–6 mm downstream from
the tip of the spray capillary, the laser beam with average output
energy of 0.3 mJ/pulse was used to ablate the tissue sample at
right angle. Optical microscopy of the burn pattern produced on a
photographic paper indicated that the laser spot size had
,300 mm diameter.
The electrospray system was similar to the one described in
recent reports from our laboratory [36,37,38]. Briefly, a home-
built electrospray system with a low-noise syringe pump (Physio
22, Harvard Apparatus, Holliston, MA) was used to feed the 50%
methanol solution containing 0.1% (v/v) acetic acid through a
stainless steel emitter with 320 mm o.d. and a tapered tip of 50 mm
i.d. (MT320-50-5-5, New Objective Inc., Woburn, MA). Stable
high voltage (2800 V) was generated by a regulated power supply
(PS350, Stanford Research Systems, Inc., Sunnyvale, CA) and was
directly applied to the emitter. The orifice of the sampling cone
was on-axis with the electrospray emitter at a distance of 12 mm
from its tip.
The cells of interest were grown to a similar population size (to
produce ,10
6 cells/pellet) before subjecting them to LAESI
experiments. The cells were quickly washed twice with phosphate
buffered saline (PBS) and pelleted by spindown (2000 rpm). The
supernatant PBS was completely removed without disturbing the
pellet and a ,10 ml fraction of the pellet was loaded onto a
microscope slide for direct LAESI analysis. Under our experi-
mental conditions, the actual number of cells ablated during
LAESI analysis is much lower (,2800 cells/laser shot). The
microscope slide with the cell pellet was held at ambient
temperature and was positioned 15 mm below the spray axis.
The microscope slide was mounted on a computer-controlled
stepper motor-driven three-axis precision flexure stage (Nanomax
TS, Thorlabs, Newton, NY) for rastering and geometry optimi-
zation.
The LAESI ion source was mounted on a Q-TOF Premier mass
spectrometer (Waters, Milford, MA). Full scan mass spectra were
recorded over the mass range of m/z 50–2,000 using a time-of-
flight (TOF) analyzer at a resolution of 8,000 (FWHM). Individual
measurements on the T-cells took a few seconds. For structure
identification of the metabolites, collision induced dissociation
spectra were recorded by selecting the precursor ion using a
quadrupole analyzer (transmission window 2 Da) and the product
ions were resolved by the TOF analyzer. Argon was used as the
collision gas at a typical collision cell pressure of 4610
23 mbar,
and a collision energy set between 5 and 25 eV. Accurate masses
were determined using the internal standard method. Glycine,
methionine, N-acetyl phenylalanine, leucine enkephalin and
glufibrinopeptide were dissolved at the appropriate concentrations
(50–200 mM) in the electrospray solution and used as internal
standards. Averages of the LAESI spectra collected under similar
experimental conditions for a fixed time window were considered
so that the approximate number of cells used for obtaining LAESI
spectra were the same for all the studied cell types.
The human metabolome database (HMDB; www.hmdb.ca), the
MassBank high resolution mass spectral database (www.massbank.
jp), the NIST/EPA/NIH mass spectral library, and the MetaCyc
database (http://metacyc.org) were used with a mass tolerance
ranging from 0.1 to 0.01 Da for the metabolite searches and
identifications.
Enzyme assays
Arginase activity was measured using the QuantiChrom
Arginase Assay Kit (BioAssay Systems, Hayward, CA) according
to the manufacturer’s instructions. CEM and C81 cell lysates (10
and 100 mg) were measured in triplicates. The concentration of
cAMP was measured using the CatchPoint Cyclic-AMP Fluores-
cent Assay Kit (Molecular Devices, Sunnyvale, CA) according to
the manufacturer’s instructions. CEM and C81 cell lysates (10 and
100 mg) were measured in triplicates. Glutathione reductase from
CEM and C81 cell lysates (10 and 200 mg) was measured utilizing
the Glutathione Reductase Assay Kit (Sigma, St. Louis, MO)
according to the manufacturer’s instructions.
Results
CEM and C81 cells
The initial experiments focused on populations of non-HTLV1
transformed (CEM) and HTLV1 transformed (C81) T lympho-
cytes. These non-adherent cells were grown in RPMI medium
composed of inorganic salts, sugar, amino acids, vitamins and
antibiotics. To minimize the interfering peaks from the medium in
the LAESI spectra, the cells were quickly washed with PBS and the
cell pellet was loaded onto a microscope slide. The cells were
directly ablated by multiple laser shots and the average LAESI
spectra (10–15 scans) were used for studying the metabolic
changes. The resulting positive ion spectra exhibited various cell
related metabolite ions in the range of m/z 20–1500, but also
included a few interfering peaks from the PBS and the medium left
in the cell pellet. Typical LAESI spectra obtained from CEM and
C81 cells are shown in Figure 1. The metabolite peaks observed in
the spectra were identified based on the accurate masses, isotope
distribution patterns and structural information obtained from
tandem MS. The background corrected spectra recorded from the
cells consisted of protonated, sodiated and potassiated species. The
observed peaks were due to small metabolites (,m/z 500), lipids
(between m/z 690 and 850) and multiply charged peaks between
m/z 700 and 1300. Deconvolution of all multiply charged peaks
(m/z 710, 828, 993 and 1241) revealed that they corresponded to
a single species with a nominal molecular weight of 4960.6,
probably related to a peptide.
The spectra of CEM and C81 cells showed a similar set of ions,
except for the lipid peaks, but consistent differences could be
identified in their relative ion yields. The detected cell-specific
metabolite ions and their peak assignments, based on accurate
mass and tandem mass spectral data, are summarized in Table 1.
All the key metabolites were confirmed by comparing their
tandem mass spectra with the spectra of the corresponding
standards or with spectra from tandem MS databases. The
detected structure-specific fragment ions are listed in Table 1.
Typical tandem mass spectra, used to identify spermine (m/z
203.2), glutathione (m/z 308.1), a phosphocholine lipid (PC(34:1),
m/z 760.6) and adenosine monophosphate (m/z 348.1), are
shown in Figure 2. Theoretically for the m/z 330.0738 ion two
structures can be assigned, namely protonated cyclic AMP
(cAMP) or sodiated glutathione. Even if both the ions are
contributing to m/z 330 (as tested with standards), it is impossible
to distinguish these two ions with the available mass resolution
(m/Dm <10,000 compared to the necessary 25,000). Comparing
the tandem mass spectrum of the m/z 330 ion from the T
lymphocytes with the tandem MS of the m/z 330 ions generated
from the two standards revealed that the ion in the cell spectra
was a sodiated glutathione (Figure 3). However, contribution of
cAMP below the levels required for obtaining a tandem mass
spectrum cannot be ruled out. In fact, cAMP was reported in T
lymphocytes at the levels of 6 pmoles/10
7 cells. The overwhelm-
ing interference from glutathione may be the cause of the
difficulty in confirming the presence of cAMP by tandem MS
under the experimental conditions used.
Viral Transformation of Cells
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and spermine (Figure 4) were observed in the spectra and
designated as degradation products a, b and c in Table 1.
Formation of these products was confirmed based on the
comparison of the LAESI data from standard polyamines with
those detected in T lymphocytes at similar experimental
conditions. The ion m/z 72 primarily results from putrescine,
and m/z 129 and 112 can be formed from both spermidine and
spermine, probably mostly from the latter due to its higher ion
yields. The abundances of these degradation products between the
non-HTLV1 transformed and HTLV1 transformed cells track
those of their precursors.
In previous reports, we had demonstrated that LAESI spectra
provided relative quantitation in a wide dynamic range [36,38].
Hence, the relative abundances of the detected ions in the LAESI
spectra of non-HTLV1 transformed and HTLV1 transformed
cells were used to gauge the extent of metabolic changes between
them. The background peaks from PBS/medium solution were
used as internal standards to improve the accuracy of mass
calibration. The relative abundance ratios for each ion detected in
CEM and C81 are listed in Table 1. Some metabolites were
detected as more than one ionic species (protonated, sodiated and
potassiated). For example, glutathione was detected as six different
ionic species. In such cases, the sum of the relative abundances of
all the related species was used to calculate the abundance ratio. In
case a particular peak was absent in a spectrum, the background
(base line signal) was used to calculate the ratio. Upregulation was
measured by the abundance ratio of ions from HTLV1
transformed over non-HTLV1 transformed cells, whereas down-
regulation was measured by the inverse ratio. A ratio close to 1.0
signified no change. The changes in the levels of the detected
metabolites between CEM and C81 cells from triplicate
experiments are shown in Figure 5.
Traces of glucose (relative abundance ,3%), the major
component of the medium (11 mM), appeared in the LAESI
spectra of the T lymphocytes. The mass of protonated spermine
(203.2236) was close to that of sodiated glucose species (203.059),
but these two peaks were well separated. This, however, raised the
issue of possible contribution of medium-related peaks to the
spectra detected from T lymphocytes. The LAESI spectrum of the
medium alone showed arginine (m/z 175), choline (m/z 104) and
glutathione (m/z 308) that potentially contributed to the signal
from the related metabolites in T lymphocytes. The glutathione
and choline peaks were less than ,2% with respect to the glucose
peak (m/z 203, base peak), whereas the arginine peak was
approximately 25–30%. These ratios were consistent with values
from diluted medium (100 times). The glucose peak appeared in
both CEM and C81 cells (,3%) with an abundance ratio for m/z
203 close to unit value. The arginine peak that was found to be
negligible in CEM cells was much higher than the glucose peak in
C81 cells. This confirmed that the arginine interferences from the
medium were negligible and the arginine levels were indeed
upregulated in C81 cells.
Metabolic changes
Among the detected ions in the low mass region (,m/z 500),
after correcting for the medium and electrospray related
background peaks, there were about 43 ions exclusively related
to T lymphocytes. Out of the 43 ions, 37 corresponded to 21
metabolites as seen in Table 1. The unassigned ions showing
variations in their relative abundances between the non-HTLV1
transformed and the HTLV1 transformed cells are included in the
footnote of Table 1. Many metabolites were downregulated in the
HTLV1 transformed cells, e.g., spermine, choline, phosphocho-
line, glycerophosphocholine, and glutathione, whereas the levels of
pyrrolidine, creatine, arginine, dopamine and adenosine mono-
phosphate were upregulated.
Lipid levels
We detected several glycerophosphocholine (PC) lipids in the
LAESI spectra of the T lymphocytes. Dramatic changes were
observed in the lipid abundances and types between non-HTLV1
transformed and HTLV1 transformed cells (expanded spectra are
shown in Figure 6). Tandem mass spectra of all major lipid peaks
yielded a single product ion at m/z 184 (a typical spectrum of the
m/z 760.6 ion is shown in Figure 2C) that confirmed that they
belong to PC lipids. Based on tandem mass spectrometric and
accurate mass information, the detected lipid peaks were
Figure 1. Positive ion LAESI mass spectra of T lymphocytes. Peaks marked in A) non-HTLV1 transformed CEM T lymphocytes and B) HTLV1
transformed C81 T lymphocytes with an asterisk (*) indicate multiply charged ions of a peptide. Inset in panel A) shows the isotope pattern of the
peak at m/z 993.5 with five charges.
doi:10.1371/journal.pone.0012590.g001
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(H9-Tax1) T cells.
No.
Metabolite
(chemical formula) Ion
Measured
mass
*
Error
(mDa)
Tandem MS
fragment ions
Abundance Ratios
*
(CEM, C81)
Abundance Ratios
(H9, H9-Tax1)
Up
# Down
# Up Down
1 Thioacetamide (C2H5NS) [M+H]+ 76.0236 1.5 - 2.4 (0.6) - -
2 Putrescine (C4H12N2)[ M +H]+ 89.1103 2.4 3 (2) - 3.2
Pyrrolidine/Degradation
product a, (C4H9N)
[M+H]+ 72.0798 21.5 2.1 (0.1)
3 Choline (C5H14NO) [M+H]+ 104.1087 1.2 60,58 - 1.9 (0.5) - 2.9
4 Proline (C5H9NO2)[ M +H]+ 116.0709 20.3 70 - 2.1 (1.1) - 10.1
[M+Na]+ 138.0564 3.3
[M+K]+ 154.0299 2.9
5 Taurine (C2H7NO3S) [M+H]+ 126.0259 3.4 - 2.9 (0.6) - 1.7
[M+Na]+ 147.9997 24.7
6 Creatine (C4H9N3O2)[ M +H]+ 132.0816 4.3 90 4.6 (2.3) - 2.3 -
7 Spermidine (C7H19N3)[ M +H[
+ 146.1664 0.7 72,112,129 1.7 (0.4) - 1.0 -
8 p-Aminobenzoic acid
(C7H7NO2)
[M+Na]+ 160.039 1.6 2.7 (0.4) - - 1.7
9 Iminoaspartic acid
(C4H5NO4)
[M+K]+ 169.9866 1 - 1.6 (0.6) - 6.0
10 Arginine (C6H14N4O2)[ M +H]+ 175.1171 22.4 70,116 130,158 3.4 (2.2) - 1.2 -
11 Dopamine (C8H11NO2)[ M +Na]+ 176.074 5.3 3.0 (0.3) - - 1.4
[M+K]+ 192.0414 21.3
12 Phosphocholine
(C5H14NO4P)
[M+H]+ 184.0767 2.8 86 - 4.8 (3.3) - 4.1
13 Carbamoyl-phosphate
(CH4NO5P)
[M+2Na-H]+ 185.9544 1.4 - 2 (0.2) - 3.5
14 Spermine (C10H26N4)[ M +H]+ 203.2259 2.3 112,129 - 2.3 (0.9) - 1.8
Degradation product c
(C7H13N)
[M+H]+ 112.1068 24.0 84 1.7 (0.2)
Degradation product b
(C7H16N2)
[M+H]+ 129.1422 3.0 112, 84 1.7 (0.4)
15 Methoxytyramine
(C9H13NO2)
[M+K]+ 206.0537 24.6 - 5.3 (1.7) - 3.7
16 N-acetyl aspartic acid/
N-formyl glutamic acid
(C6H9NO5)
[M+K]+ 214.0088 23 2.1 (0.5) - 1.7 -
17 Homovanillic acid (C9H10O4)[ M +K]+ 221.0208 20.8 3.5 (1.3) - 1.3 -
18 Glycerophosphocholine
(C8H20NO6P)
[M+H]+ 258.1124 1.7 104 - 2.4 (1) - 6.1
[M+Na]+ 280.0961 3.5
[M+K]+ 296.0724 5.9
19 Glutathione (C10H17N3O6S) [M+H]+ 308.0904 21.2 162,179, 233 - 4.6 (1.5) - 9.8
[M+Na]+ 330.0738 0.2
[M+2Na-H]+ 352.0518 23.7
[M+Na+K-H]+ 368.0315 2
[M+3Na-2H]+ 374.0388 1.3
[M+2Na+K-2H]+ 390.0125 1.1
20 8-Hydroxyguanosine
(C10H13N5O6)
[M+K]+ 338.053 2.7 - 1.9 (1) - -
21 Adenosine monophosphate
(C10H14N5O7P)
[M+H]+ 348.0712 0.3 136 7.6 (1.2) - 3.1 -
Viral Transformation of Cells
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glycerophosphocholines (PC(Cn:dbn), where Cn = the total
number of carbons and dbn = the total number of double bonds
in two fatty acid side chains, and alkylacyl/alkenylacyl glyceropho-
sphocholines or plasmalogens, (PC(O-Cn:dbn)). The measured
relative abundance ratio values are also incorporated in Table 2.
No.
Metabolite
(chemical formula) Ion
Measured
mass
*
Error
(mDa)
Tandem MS
fragment ions
Abundance Ratios
*
(CEM, C81)
Abundance Ratios
(H9, H9-Tax1)
Up
# Down
# Up Down
[M+Na]+ 370.0505 22.4 158
[M+2Na-H]+ 392.0298 25
Up and down regulation is followed by abundance ratios.
#The values in parentheses are standard deviation from triplicate experiments.
*Unassigned ions were detected at m/z 158.1572 (2.5), 228.0363 (2.6), 260.0298 (3.6), 311.9216 (1.5), 333.9604 (2.2), and 346.0616 (1.2), where the values in parenthesis
were the abundance ratio C81/CEM.
doi:10.1371/journal.pone.0012590.t001
Table 1. Cont.
Figure 2. Tandem MS with collision induced dissociation for metabolite identification. A) protonated spermine (m/z 203.2), B) protonated
glutathione (m/z 308.1) and C) protonated glycerophosphocholine lipid (PC(34:1), m/z 760.6) in CEM T lymphocytes, and of D) protonated adenosine
monophosphate (AMP, m/z 348.1) in C81 T lymphocytes were directly analyzed by LAESI.
doi:10.1371/journal.pone.0012590.g002
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ulated in HTLV1 transformed cells. Only a few lipids were
retained in the HTLV1 transformed cells, and the levels of
PC(30:0), PC(O-31:2), PC(32:3), PC(32:0), and PC(O-33:3) were
found to be higher compared to non-HTLV1 transformed cells.
As m/z 184 and 104 appeared in the LAESI spectra of the T
lymphocytes and were also observed as collision induced
dissociation (CID) products, the question of in-source fragmenta-
tion/degradation of lipids arises. When the LAESI spectrum was
recorded for a standard lipid (PC(16:0/18:1)) under similar
experimental conditions, the fragment ions m/z 104 and 184
were marginally observed (,0.5%). This confirms that the
detected choline peaks correspond to metabolites and not to
CID artifacts.
Metabolite confirmation
The observed changes in metabolite levels between non-
HTLV1 transformed and HTLV1 transformed T lymphocytes
Figure 3. Tandem MS of m/z 330 obtained from standards and T lymphocytes. A) cyclic AMP standard (protonated), B) glutathione
standard (sodiated) and C) CEM T lymphocytes were analyzed by LAESI and CID. Panels A) and B) show that the fragment ion m/z 136 is specific to
AMP, whereas the fragment ions m/z 313, 285, 201 and 152 are specific to the sodiated glutathione. Thus the m/z 330 ion produced from CEM T
lymphocytes in panel C) can be attributed to sodiated glutathione.
doi:10.1371/journal.pone.0012590.g003
Figure 4. Degradation of putrescine, spermidine and spermine
under LAESI experimental conditions.
doi:10.1371/journal.pone.0012590.g004
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enzyme or protein involved in the related metabolic pathway.
We measured the levels of cAMP, arginase, and glutathione
reductase in CEM and C81 cells using biochemical assays.
Arginase and cAMP levels were upregulated, whereas the
glutathione reductase levels were downregulated in the HTLV1
transformed C81 cells compared to the non-HTLV1 trans-
formed CEM cells (Figure 7). Therefore, these assay results
correlated with the detected changes in the corresponding
metabolites.
Figure 5. Metabolic differences between CEM and C81 cells detected by LAESI-MS.
doi:10.1371/journal.pone.0012590.g005
Figure 6. Expanded positive ion LAESI mass spectra showing glycerophosphocholine lipid peaks. Peaks marked with an asterisk (*) in A)
CEM T lymphocytes B) HTLV1 transformed C81 T lymphocytes indicate multiply charged ions of a peptide.
doi:10.1371/journal.pone.0012590.g006
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Sl. No. Lipid
* Chemical formula Ion Monoisotopic mass Observed mass Error (mDa) MS/MS Abundance ratio
C81/CEM CEM/C81
1 PC(29:1) C37H72NO8P[ M +H]+ 690.5074 690.5145 7.1 7.4
2 PC(O-30:0) C38H78NO7P[ M +H]+ 692.5594 692.5631 3.7 3.8
3 PC(O-31:2) C39H76NO7P[ M +H]+ 702.5438 702.5402 23.6 7.7
4 PA O-37:1) C40H79O7P[ M +H]+ 703.5642 703.5730 8.8 2.4
5 PC(O-31:1) C39H78NO7P[ M +H]+ 704.5594 704.5579 21.5 2.6
6 PC(30:0) C38H76NO8P[ M +H]+ 706.5387 706.5424 3.7 184 1.7
7 PC(O-30:0) C38H78NO7P[ M +Na]+ 714.5414 714.5346 26.8 2.7
8 PC(O-32:1) C40H80NO7P[ M +H]+ 718.5751 718.5652 29.9 184 18.9
9 PC(O-32:0) C40H82NO7P[ M +H]+ 720.5907 720.5859 24.8 2.9
10 PC(O-31:2) C39H76NO7P[ M +Na]+ 724.5257 724.5173 28.4 1.1
11 PA(O-37:1) C40H79O7P[ M +Na]+ 725.5461 725.5467 0.6 1.6
12 PC(32:3) C40H74NO8P[ M +H]+ 728.523 728.5212 21.8 1.5
13 PC(32:2) C40H76NO8P[ M +H]+ 730.5387 730.5436 4.9 2.7
14 PC(32:1) C40H78NO8P[ M +H]+ 732.5543 732.5537 20.6 1.8
15 PC(32:0) C40H80NO8P[ M +H]+ 734.57 734.5748 4.8 184 2
16 PC(O-32:1) C40H80NO7P[ M +Na]+ 740.5570 740.5496 27.4 8.3
PC(O-34:4) C42H78NO7P[ M +H]+ 740.5594 740.5496 29.8
17 PC(33:3) C41H76NO8P[ M +H]+ 742.5387 742.5509 12.2 2.2
18 PC(33:2) C41H78NO8P[ M +H]+ 744.5543 744.5550 0.7 10.6
19 PC(O-34:1) C42H84NO7P[ M +H]+ 746.6064 746.5976 28.8 184 15.2
20 PC(O-33:3) C41H78NO7P[ M +Na]+ 750.5414 750.5430 1.6 1.1
21 PC(O-33:2) C41H80NO7P[ M +H]+ 752.5570 752.5501 26.9 13
22 PC(34:4) C42H76NO8P[ M +H]+ 754.5387 754.5388 0.1 1.3
23 PC(32:0) C40H80NO8P[ M +Na]+ 756.5519 756.5451 26.8 2.4
PC(34:3) C42H78NO8P[ M +H]+ 756.5543 756.5451 29.2
24 PC(34:2) C42H80NO8P[ M +H]+ 758.57 758.5577 212.3 2.4
26 PC(34:1) C42H82NO8P[ M +H]+ 760.5856 760.5847 20.9 184 2.1
27 PC(O-36:5) C44H80NO7P[ M +H]+ 766.5751 766.5663 28.8 11.3
28 PC(O-34:1) C42H84NO7P[ M +Na]+ 768.5883 768.5800 28.3 14.5
PC(O-36:4) C44H82NO7P[ M +H]+ 768.5907 768.5800 210.7
29 PC(35:3) C43H80NO8P[ M +H]+ 770.57 770.5699 20.1 3.7
30 PS(O-34:0) C40H80NO9P[ M +Na]+ 772.5468 772.5480 1.2 5.4
31 PC(35:1) C43H84NO8P[ M +H]+ 774.6013 774.6147 13.4 56.5
32 PC(36:5) C44H78NO8P[ M +H]+ 780.5543 780.558 3.7 3.1
33 PC(36:4) C44H80NO8P[ M +H]+ 782.57 782.5715 1.5 184 1.3
34 PC(36:3) C44H82NO8P[ M +H]+ 784.5856 784.5753 210.3 3.4
35 PC(36:2) C44H84NO8P[ M +H]+ 786.6013 786.6064 5.1 5
36 PC(36:1) C44H86NO8P[ M +H]+ 788.6169 788.6153 21.6 8.9
37 PC(O-36:3) C44H84NO7P[ M +Na]+ 792.5883 792.5933 5.0 7.4
38 PC(37:5) C45H80NO8P[ M +H]+ 794.5700 794.5802 10.2 10.6
39 PC(37:4) C45H82NO8P[ M +H]+ 796.5856 796.5962 10.6 184 36.8
40 PC(36:3) C44H82NO8P[ M +Na]+ 806.5676 806.5585 29.1 4.1
PC(38:6) C46H80NO8P[ M +H]+ 806.5700 806.5585 211.5
41 PC(38:5) C46H82NO8P[ M +H]+ 808.5856 808.5864 0.8 5.8
42 PC(38:4) C46H84NO8P[ M +H]+ 810.6013 810.5938 27.5 184 7.3
Up and down regulation are followed by C81/CEM and CEM/C81 abundance ratios, respectively.
*PC = diacyl glycerophosphocholine, PC O- = alkylacyl or alkenylacyl glycerophosphocholine.
doi:10.1371/journal.pone.0012590.t002
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To determine if our observations were cell line specific and to
explore the role of Tax1 expression, the LAESI experiments were
extended to other cell lines, e.g., non-HTLV1 transformed T
lymphocytes (H9), their Tax1-transfected counterparts (H9-Tax1)
and HTLV1-transformed cells (HUT102 cells). The detected
metabolites in these cells were found to be similar to the CEM and
C81 cells with minor variations in the ion yields. The metabolic
changes upon transfection are listed in Table 3. The pattern of
down- and upregulation of key metabolites, such as glutathione
and adenosine monophosphate, respectively, remained similar to
the CEM/C81 case. These results suggest that the metabolic
changes observed in the HTLV1 transformed cells can, in part, be
attributed to Tax1 expression.
293T vs. 293T-HTLV3 and 293T-Tax3 cells
To determine the specificity of the observed metabolite changes
to HTLV1 transformation, we performed LAESI experiments on
non-HTLV3 transformed 293T kidney epithelial cells, and on
HTLV3 and Tax3 transfected 293T cells. Although the 293T cells
showed a variety of ions that were not detected in the CEM, C81,
H9 and HUT102 cells (see Table 4), there were some metabolites
common to all these cells (see Table 3). The observed changes for
HTLV3 and Tax3 transfected 293T cells did not match those
found in HTLV1 transformed cells. For example, the lipid peaks
that showed prominent changes in the HTLV1 transformed cells
were found to be unaltered in HTLV3/Tax3 affected 293T cells
(data not shown).
Discussion
In this study we detected the changes in various metabolite and
lipid levels upon HTLV transformation and Tax expression in T
lymphocytes and kidney epithelial cells. Among the metabolites
identified, glutathione, spermine, choline, phosphocholine, glycer-
ophosphocholine, thioacetamide, proline, taurine, carbamoyl
phosphate, methoxytyramine and 8-hydroxy guanosine were
downregulated in the C81 vs. CEM cells, whereas the levels of
creatine, arginine, dopamine, homovanillic acid and AMP were
upregulated. Some of the key metabolic changes detected in C81
cells were also observed in H9-Tax1 vs. H9 and HUT102 vs. H9
cells. These metabolites participate in several biochemical
pathways, such as polyamine biosynthesis, creatine biosynthesis,
AMP biosynthesis, dopamine metabolism, lipid metabolism, redox
reactions etc. Their biological importance and relevance to
transformation and/or Tax expression is discussed below.
HTLV1 transformation specific metabolites
There were a few metabolites, including putrescine, taurine,
arginine, and adenosine monophosphate, that were differentially
regulated in HTLV1 transformed cells. These metabolites were
not detected in HTLV3 or Tax3 transfected cells, indicating that
they were specific to HTLV1 induced transformation.
Putrescine, along with spermine and spermidine belong to the
polycationic compounds named polyamines [46] present in all
living cells. Due to electrostatic interactions between the positively
charged ammonium groups of the polyamines and the negatively
charged phosphates of nucleic acids, they often associate. They are
involved in genetic processes such as DNA synthesis and gene
expression and play a major role in cell proliferation, cell
differentiation, and programmed cell death. The biosynthesis of
polyamines is tightly regulated in cells, and ornithine in the urea
cycle is their precursor (Figure 8). Therefore, the levels of each
polyamine are linked to the actual status of the cell. In the present
study, spermine levels were found to be somewhat lower in all the
transformed cells (except for the case of HUT102), whereas the
levels of putrescine and spermidine, the precursors of spermine,
were upregulated in HTLV1 transformed cells. Spermidine was
also upregulated in the 293T-HTLV3 and the 293T-Tax3 cell
lines. This reveals that the expression of full length HTLV3 or just
Tax3 affects the tightly regulated biosynthesis of polyamines in the
cells, thereby causing disturbances in the genetic processes.
Although the trends for individual amines were not completely
consistent among HTLV1 transformed cells, the effect of viruses
on the overall polyamine biosynthesis is clearly reflected. Further
studies are required to explore whether the individual amine levels
correlate with the stage of the viral transformation.
Interestingly, arginine that is converted into ornithine, the
precursor of polyamines in the urea cycle, was also upregulated in
Figure 7. Confirmation of metabolic changes using conven-
tional biochemical assays. A) Arginase activity was measured using
the QuantiChrom Arginase Assay Kit (BioAssay Systems). CEM and C81
cell lysates (10 mg and 100 mg) were measured in triplicates. B) The
concentration of cAMP was measured using the CatchPoint Cyclic-AMP
Fluorescent Assay Kit (Molecular Devices). CEM and C81 cell lysates
(10 mg and 100 mg) were measured in triplicates. C) Glutathione
reductase from CEM and C81 cell lysates (10 mg and 200 mg) was
measured utilizing the Glutathione Reductase Assay Kit (Sigma).
doi:10.1371/journal.pone.0012590.g007
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transfected and Tax1 or Tax3 expressing cells (293-HTLV3, H9-Tax1, 293-Tax3, respectively).
No.a Metabolite (chemical formula) CEM vs. C81 H9 vs. H9-Tax1 H9 vs. HUT102
293T vs.
293T-HTLV3
293T vs.
293T-Tax3
Up Down Up Down Up Down Up Down Up Down
1 Thioacetamide (C2H5N S ) -2 . 4 -- - - -- --
2 Putrescine (C4H12N2) 3 - 3.2 - 6.1 - - - - -
Pyrrolidine/Degradation product a,( C 4H9N)
3 Choline (C5H14NO) - 1.9 - 2.9 2.4 - - 2.4 - 2.5
4 Proline (C5H9NO2) - 2.1 - 10.1 1.2 - - - - -
5 Taurine (C2H7NO3S) - 2.9 - 1.7 - 3.9 - - - -
6 Creatine (C4H9N3O2) 4.6 - 2.3 - - - - 2.0 1.6 -
7 Spermidine (C7H19N3) 1.7 - 1.0 - 1.3 - 2.0 - 2.2 -
8 p-Aminobenzoic acid (C7H7NO2) 2.7 - - 1.7 - 1.2 - 3.6 3.4 -
9 Iminoaspartic acid (C4H5NO4) - 1.6 - 6.0 1.4 - - 2.4 1.9 -
10 Arginine (C6H14N4O2) 3.4 - 1.2 - 22.7 - - - - -
11 Dopamine (C8H11NO2) 3.0 - - 1.4 2.5 - - - - -
12 Phosphocholine (C5H14NO4P) - 4.8 - 4.1 1.2 - - 4.0 - 1.5
13 Carbamoyl-phosphate CH4NO5P -2 -3 . 5 3 . 4 - -- --
14 Spermine (C10H26N4) - 2.3 - 1.8 1.8 - - 2.0 - 1.2
Degradation product c (C7H13N)
Degradation product b (C7H16N2)
15 Methoxytyramine (C9H13NO2) - 5.3 - 3.7 - 4.7 - 5.0 2.9 -
16 N-acetyl aspartic acid/N-formyl glutamic
acid (C6H9NO5)
2.1 - 1.7 - 3.9 - 4.8 - 2.9 -
17 Homovanillic acid (C9H10O4) 3.5 - 1.3 - - - - 16.5 - 6.8
18 Glycerophosphocholine (C8H20NO6P) - 2.4 - 6.1 25.6 - - 3.5 - 4.4
19 Glutathione (C10H17N3O6S) - 4.6 - 9.8 - 2.1 - 1.5 3.8 -
20 8-Hydroxyguanosine (C10H13N5O6) -1 . 9 -- - - -- --
21 Adenosine monophosphate (C10H14N5O7P) 7.6 - 3.1 - 21.5 - - - -
aThe metabolite numbers are according to the list provided in Table 1.
doi:10.1371/journal.pone.0012590.t003
Table 4. Additional metabolites detected in 293T, 293T-HTLV3 and 293T-Tax3 cells, and their abundance ratios indicating up and
down regulation due to HTLV3 transfection or the presence of Tax3.
Additional metabolites detected in 293T, 293T-HTLV3 and 293T-Tax3 cells
293T vs. 293T-
HTLV3
293T vs.
293T-Tax3
No. Metabolite Ion Measured mass Error (mDa) Up Down Up Down
22 5-Aminoimdazole (C3H5N3)[ M +H]
+ 84.0705 14.3 - 2.2 1.7 -
23 Dimethyl sulfide (C2H6S) [M+Na]
+ 85.0097 0.9 1.9 - 2.2 -
24 Sarcosine/Alanine (C3H7NO2)[ M +H]
+ 90.0525 -3 - 2.5 - 1.1
25 Glycerol (C0H8O3)[ M +Na]+ 115.021 216.1 8.0 - - 1.6
26 Glutarate semialdehyde (C5H8O3)[ M +H]
+ 117.0277 227.5 2.5 - 3.1 -
27 Succinic acid (C4H6O4)[ M +H]
+ 119.0276 26.8 - 3.3 - 1.5
28 Amino malonic acid (C3H5NO4)[ M +H]+ 120.0118 217.3 2.7 - 4.8 -
29 Homoserine/threonine (C4H9NO3)[ M +H]
+ 120.0803 14.2 - 3.0 - 2.9
30 Creatinine (C4H7N3O) [M+Na]
+ 136.0486 20.1 3.7 - 2.7 -
31 Betaine (C5H11NO2)[ M +K]
+ 156.0464 3.7 - 3.2 2.2 -
32 2-Aminomuconic acid semialdehyde (C6H7NO3)[ M +Na]
+ 164.0272 25.2 - 1.9 3.0 -
33 Mannitol/Sorbitol (C6H14O6)[ M +Na]
+ 205.0655 23.3 - 36 - 20
doi:10.1371/journal.pone.0012590.t004
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Upregulation of arginase in transformed cells as detected by the
enzyme assay (Figure 7B), is consistent with the elevated levels of
arginine upon viral transformation. Deprivation of arginine causes
serious disturbances in cellular function and enhances apoptosis
[47]. The role of arginine in the survival of endothelial cells during
oxidative stress has also been demonstrated [48]. A recent report
shows regulation of T lymphocyte function in cancer by arginine
availability [49]. Arginine is also a precursor in the biosynthesis of
creatine (Figure 8), an important molecule in energy supply.
Prevalence of abnormal creatine phosphokinase levels in the blood
of HTLV2 infected patients has been reported [50]. Recently, it
was shown that the enzymes related to creatine and arginine
metabolism were found to be significantly upregulated in
malignant cells [51]. Finding upregulation of arginine and
putrescine in HTLV1 transformed cells highlights the importance
of polyamine and creatine biosynthesis for energy production to
support the high rates of cellular proliferation that is common for
transformed cells.
Levels of phosphorylated adenosine nucleotides, including ATP,
ADP and AMP, define the energy state in living cells. Quantitation
of individual adenine nucleotides is frequently used for the
assessment of the energy state of cells [52,53,54]. The level of
exogenous ATP in the body may be increased in various
inflammatory and shock conditions. The importance of extracel-
lular ATP for cell-to-cell communication and in the immune
system is known [55,56,57]. Classical HPLC based metabolomic
technologies have been used to detect and quantify these
molecules [13,54,58].
Here we detected AMP directly from cells using the LAESI
technique. Significantly elevated AMP abundance was observed in
HTLV1 and Tax1 transformed cells. AMP can be formed by the
dephosphorylation of ATP/ADP or by the hydrolysis of cAMP
(Figure 9A). Apart from being a degradation product of ATP,
AMP is known to activate the AMP-activated kinase (AMPK)
system that is ubiquitously expressed in mammalian cells. It is
involved in the response to a variety of metabolic stresses that
disturb the cellular energy homeostasis [59,60,61]. The cause of
elevated AMP levels in HTLV1 and Tax1transformed cells
requires further investigation.
cAMP is a second messenger and activates several protein
kinases that are involved in significant biochemical processes. The
amount of cAMP known to be present in T lymphocytes is
,6 pmol/10
7 cells. We had difficulty in the detection of cAMP by
LAESI-MS due to an overwhelming spectral interference from
glutathione. A mass spectrometer with better resolving power
could separately detect these two species. We applied an
alternative immunoassay method to measure the levels of cAMP
(Figure 7). The cAMP levels (adenylyl cyclase activity, Figure 9A)
were increased in HTLV1 transformed cells compared with non-
HTLV1 transformed cells. Importantly, targeting of cAMP
pathway has been explored as a potential therapeutic option for
the treatment of leukemia/lymphoma and therefore, could also be
useful for the treatment of ATL [62]
We identified dopamine, a neuromodulator, and its metabolites,
methoxytyramine and homovanillic acid, in the studied T
lymphocytes. Dopamine belongs to the group of catecholamines,
and is involved in the neuroimmunological network [63]. T
lymphocytes can be activated by neurotransmitters via neuro-
transmitter receptors that can elicit crucial functions [64].
Synthesis of catecholamines in mouse lymphocytes, and their
increased levels in the activated state was noticed earlier [63,65].
Dopamine can be biosynthesized in the body from tyrosine, and
the related metabolic pathways are also well established (see, e. g.,
Figure 9B). In the present study we found upregulation of
dopamine and homovanillic acid levels and downregulation of
methoxytyramine in HTLV1 transformed cells. To our knowledge
changes in these metabolites have never been documented for
HTLV transformed cells. Considering their implications in
neuronal processes, it would be interesting to determine if they
were also deregulated in HAM/TSP patient samples and
understanding how changes in their expression relate to this
diseased state.
293T vs. 293T-HTLV3 metabolites
Transfection of 293T cells with HTLV3 molecular clone
resulted in the downregulation of many of the metabolites
detected in the HTLV1 transformed cells. In fact, only two
metabolites (spermidine and N-acetyl aspartic acid) were upregu-
lated in both HTLV1 transformed and HTLV3 transfected cells.
There were additional metabolites detected (see Table 4), which
are likely to be reflective of cell type differences, as they were only
found in the 293T cell experiments.
One particularly interesting metabolite is glutathione. Glutathi-
one was downregulated in HTLV3 transfected cells as well as
HTLV1 transformed cells, indicating that downregulation of
glutathione is a consequence of viral infection, not necessarily the
transformation process. The reduced form of glutathione (GSH) is
the most predominant thiol present in mammalian cells with
concentrations up to 12 mM [66]. GSH serves several important
Figure 8. Metabolites in the creatine and polyamine biosyn-
thesis pathways detected by LAESI-MS in T lymphocytes.
doi:10.1371/journal.pone.0012590.g008
Figure 9. Metabolites related to A) adenosine monophosphate
(AMP) and B) dopamine detected by LAESI-MS in T lympho-
cytes.
doi:10.1371/journal.pone.0012590.g009
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cofactor in isomerization reactions, transport and storage form of
cysteine, and regulator of intracellular redox status, cell prolifer-
ation and apoptosis [67,68,69]. Biologically the oxidized glutathi-
one (GSSG) is converted to GSH by the enzyme glutathione
reductase. The ratio of GSH and GSSG serves as a representative
marker of the antioxidative capacity of the cell [70]. Cellular GSH
concentrations are markedly reduced in response to protein
malnutrition, oxidative stress, and many pathological conditions
and can sensitize cells to apoptosis. In fact, reducing GSH levels
through buthionine sulfoximine treatment, resulted in increased
sensitivity of HTLV1 transformed cells to 13-cis-retinoic acid
induced cell death [71].
Metabolite changes due to Tax3 expression
When comparing metabolite levels between HTLV3 and Tax3
transfected 293T cells, there were a number of common changes
observed, including decreased choline, phosphocholine, spermine,
homovanillic acid, and glycerophosphocholine and increased
spermidine and N-acetyl aspartic acid. These results indicate that
the lipid metabolism pathway as well as the creatine and
polyamine biosynthesis pathways are commonly deregulated after
expression of HTLV3 and Tax3, indicating that the noted changes
are likely due to Tax3 expression.
N-acetyl aspartic acid or N-acetylaspartate (NAA) is a novel
metabolite that is upregulated in all cell types and all conditions
tested. NAA levels are well known to be altered in diseases such as
Alzheimer’s, epilepsy and schizophrenia [72]. In addition, the
abundance of NAA in the urine is a marker for Canavan disease
(CD), which is a leukodystrophy caused by deficiency of the
enzyme aspartoacylase [73]. The expression of NAA is associated
with neuronal processes and thus the detection in lymphocytes is
unexpected. Interestingly, HTLV1 infection can result in the
neurological disorder HAM/TSP. HAM/TSP is a demyelinating
disorder and can results in the degradation of the cervical spinal
cord and the brainstem [74]. Therefore, the upregulation of NAA
may be reflective of viral induced changes that could have
important implications for HAM/TSP.
Choline containing metabolites including lipids
We found choline containing metabolites, i.e., choline, phos-
phocholine, glycerophosphocholine, and several glycerophospho-
choline lipids in the LAESI spectra of T lymphocytes and kidney
epithelial cells. Except for the HUT102 case, when compared to
non-transformed cells, all these metabolites were downregulated
upon transformation by HTLV1, HTLV3, Tax1 or Tax3. The
role of these metabolites in lipid metabolism is shown in Figure 10.
Usually, choline containing metabolites are monitored by in vivo
NMR spectroscopy, but with this technique it is difficult to
determine which specific metabolites are altered [14]. Using LAESI
MS enabled the direct monitoring of choline containing metabo-
lites. The LAESI spectra of non-transformed and transformed cells
provided information on both the precursors and lipid components
simultaneously. We also found a decrease in the glyceropho-
sphocholine lipid content in HTLV1 transformed cells confirming
increased lipid catabolism to produce fatty acids. Apart from a few
lipids (PC(30:0), PC(32:5), PC(32:3), PC(32:0), and PC(34:6) that
remained at higher levels in HTLV1 transformed cells, most of the
glycerophosphocholine lipids present in non-HTLV1 transformed
cells were downregualated in the HTLV1 transformed ones.
Conclusions and future directions
We used the LAESI technique to identify metabolic changes in
HTLV1 and Tax1 transformed T lymphocytes and in HTLV3
and Tax3 transfected kidney epithelial cells. We found virus type
specific (HTLV1 vs. HTLV3), expression specific (Tax1 vs. Tax3)
and cell type specific (T lymphocytes vs. kidney epithelial cells)
changes in the metabolite profiles. We have identified a number of
metabolites that are known in the literature to be deregulated in
the viral transformation process (e. g., arginine, cAMP, glutathi-
one) as well as multiple novel metabolites that may have
implications in HTLV1-induced transformation (e. g., putrescine,
N-acetyl aspartic acid, methoxytyramine). These new findings
point to metabolic pathways that have a heretofore unexplored
role in the viral transformation of host cells. Future studies will
focus on the elucidation of the mechanism of metabolite
deregulation and its consequences in terms of disease progression
and treatment options.
Our results also demonstrate the application of a new tech-
nique, LAESI-MS, which is capable of in situ detection of
metabolites and lipid components from the entire volume of the
cells. Because LAESI uses the native water content of the cells or
tissue to couple the laser energy into the sample, it does not
require extensive sample preparation or the application of a
matrix material.
Although cell populations are used for this study, the technique
can also be applied for analyzing intracellular metabolites from a
single cell. The LAESI method has already been utilized for the
analysis of metabolites from large single cells (e. g., sea urchin eggs
of 90 mm diameter) [43]. Since the T lymphocytes are significantly
smaller in size (10–15 mm), modifications in the sample handling,
for example, the use of micromanipulators, and reduction in the
laser spot size are required. Such advances are required to explore
cell-to-cell metabolic variations, as well as cells at different stages of
the cell cycle.
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